Vasomotor symptoms and depression in women, Part 2: Treatments that cause remission and prevent relapses of major depressive episodes overlap with treatments for vasomotor symptoms

Journal of Clinical Psychiatry

Volumn 70, Issue 3, 2009, Pages 310-311

  Stahl, Stephen M ^a,b  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; NEUROTRANSMITTER; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; ADRENERGIC RECEPTOR AFFECTING AGENT; ANTIDEPRESSANT AGENT;

DEPRESSION; FEMALE; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; RELAPSE; REMISSION; SHORT SURVEY; VASOMOTOR DISORDER; AFFECT; ARTICLE; CLIMACTERIUM; DOSE RESPONSE; DRUG EFFECT; ESTROGEN THERAPY; HYPOTHALAMUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT;

ADRENERGIC UPTAKE INHIBITORS; AFFECT; ANTIDEPRESSIVE AGENTS; CLIMACTERIC; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPOTHALAMUS; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS;

EID: 64149120716     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08bs04919     Document Type: Short Survey

References (10)

1. Stahl SM. Antidepressants. In: Stahl's Essential Psychopharmacology. 3rd ed. New York, NY: Cambridge University Press; 2008:511-666
2. Brizendine L. The Female Brain. New York, NY: Morgan Road Books; 2006
3. Wise DD, Felker A, Stahl SM. Tailoring treatment of depression for women across the reproductive lifecycle. CNS Spectrums 2008;13(8):647-662
4. Stahl SM. Vasomotor symptoms and depression in women, pt 1: role of vasomotor symptoms in signaling the onset or relapse of a major depressive episode. J Clin Psychiatry 2009;70(1):11-12
5. Soares CN, Arsenio H, Joffe H, et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women. Menopause 2006;13(5):780-786
6. Soares CN, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 2001;58(6):529-534
7. Morrison MF, Kallan MJ, Ten HT, et al. Lack of efficacy of estradiol for depression in postmenopausal women. Biol Psychiatry 2004;55(4):406-412
8. Archer DF, DuPont C, Constantine G, et al. Desvenlafaxine succinate (DVS), a novel serotonin and norepinephrine reuptake inhibitor, improves mood and menopausal symptoms in women with hot flushes (HFS) associated with menopause. Fertil Steril 2007;88:S246
9. Joffe H, Soares CN, Petrillo LF, et al. Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 2007;68(6):943-950 (Pubitemid 47015497)
10. Speroff L, Gass M, Constantine G, et al. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms. Obstet Gynecol 2008;111(1):77-87